Have a personal or library account? Click to login
Multiple Organ Dysfunction Secondary to Herpes Simplex Virus -1 Reactivation After Treatment With Dexamethasone and Sarilumab for Covid-19 Disease Cover

Multiple Organ Dysfunction Secondary to Herpes Simplex Virus -1 Reactivation After Treatment With Dexamethasone and Sarilumab for Covid-19 Disease

The Journal of Critical Care Medicine
Volume 9 (2023): Issue 2 (April 2023)
By: Thomas Roe,  Sam Waddy and  Nikitas Nikitas  
Open Access
|May 2023

Authors

Thomas Roe

tom.roe2@nhs.net

University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom

Sam Waddy

University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom

Nikitas Nikitas

University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom
DOI: https://doi.org/10.2478/jccm-2023-0010 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Journal RSS Feed
Language: English
Page range: 122 - 128
Submitted on: Aug 18, 2022
Accepted on: Feb 8, 2023
Published on: May 8, 2023
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
coronavirus,
herpes simplex virus,
reactivation,
intensive care,
multiple organ dysfunction
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Internal medicine, other,
Surgery,
Surgery, other,
Anaesthesiology,
Emergency medicine and intensive-care medicine

© 2023 Thomas Roe, Sam Waddy, Nikitas Nikitas, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 9 (2023): Issue 2 (April 2023)